Autocrine IFNγ Controls the Regulatory Function of Lymphoproliferative Double Negative T Cells

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Juvet, Stephen C ^a,b,c   Han, Mei ^a,c   Vanama, Ramesh ^a,c   Joe, Betty ^a,c   Kim, Edward Y ^a,c   Zhao, Fei Linda ^a,c   Jeon, Caroline ^a,c   Adeyi, Oyedele ^a,c   Zhang, Li ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; DOUBLE NEGATIVE T LYMPHOCYTE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; AUTOCRINE COMMUNICATION; BONE MARROW TRANSPLANTATION; FAS LIGAND PROTEIN; GRAFT VS HOST DISEASE; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84867526070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047732     Document Type: Article

References (45)

1. D'Acquisto F, Crompton T, (2011) CD3(+)CD4(-)CD8(-) (double negative) T cells: Saviours or villains of the immune response? Biochem Pharmacol 82: 333-340.
2. Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L, (2000) Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 6: 782-789.
3. Zhang D, Yang W, Degauque N, Tian Y, Mikita A, et al. (2007) New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses. Blood 109: 4071-4079.
4. Chen W, Ford MS, Young KJ, Cybulsky MI, Zhang L, (2003) Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J Immunol 170: 1846-1853.
5. Lee BP, Mansfield E, Hsieh SC, Hernandez-Boussard T, Chen W, et al. (2005) Expression profiling of murine double-negative regulatory T cells suggest mechanisms for prolonged cardiac allograft survival. J Immunol 174: 4535-4544.
6. Ford MS, Chen W, Wong S, Li C, Vanama R, et al. (2007) Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development. Eur J Immunol 37: 2234-2241.
7. Hillhouse EE, Beauchamp C, Chabot-Roy G, Dugas V, Lesage S, (2010) Interleukin-10 limits the expansion of immunoregulatory CD4-CD8- T cells in autoimmune-prone non-obese diabetic mice. Immunol Cell Biol 88: 771-780.
8. Young KJ, DuTemple B, Phillips MJ, Zhang L, (2003) Inhibition of graft-versus-host disease by double-negative regulatory T cells. J Immunol 171: 134-141.
9. Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, et al. (2005) Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood 105: 2828-2835.
10. Voelkl S, Gary R, Mackensen A, (2011) Characterization of the immunoregulatory function of human TCR-alphabeta+ CD4- CD8- double-negative T cells. Eur J Immunol 41: 739-748.
11. McIver Z, Serio B, Dunbar A, O'Keefe CL, Powers J, et al. (2008) Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation. Br J Haematol 141: 170-178.
12. Ford MS, Young KJ, Zhang Z, Ohashi PS, Zhang L, (2002) The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med 196: 261-267.
13. Hamad AR, Mohamood AS, Trujillo CJ, Huang CT, Yuan E, et al. (2003) B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production. J Immunol 171: 2421-2426.
14. Young KJ, Yang L, Phillips MJ, Zhang L, (2002) Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood 100: 3408-3414.
15. Kim S, Kim KA, Hwang DY, Lee TH, Kayagaki N, et al. (2000) Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved. J Immunol 164: 2931-2936.
16. Giese T, Davidson WF, (1994) Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J Immunol 152: 2000-2010.
17. Jevnikar AM, Grusby MJ, Glimcher LH, (1994) Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med 179: 1137-1143.
18. Refaeli Y, Van Parijs L, Alexander SI, Abbas AK, (2002) Interferon gamma is required for activation-induced death of T lymphocytes. J Exp Med 196: 999-1005.
19. Wang Z, Hong J, Sun W, Xu G, Li N, et al. (2006) Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J Clin Invest 116: 2434-2441.
20. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141.
21. Ren G, Su J, Zhao X, Zhang L, Zhang J, et al. (2008) Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide. J Immunol 181: 3277-3284.
22. Jung ID, Lee CM, Jeong YI, Lee JS, Park WS, et al. (2007) Differential regulation of indoleamine 2,3-dioxygenase by lipopolysaccharide and interferon gamma in murine bone marrow derived dendritic cells. FEBS Lett 581: 1449-1456.
23. Murray L, Martens C, (1989) The abnormal T lymphocytes in lpr mice transcribe interferon-gamma and tumor necrosis factor-alpha genes spontaneously in vivo. Eur J Immunol 19: 563-565.
24. Hill M, Thebault P, Segovia M, Louvet C, Beriou G, et al. (2011) Cell therapy with autologous tolerogenic dendritic cells induces allograft tolerance through interferon-gamma and epstein-barr virus-induced gene 3. Am J Transplant 11: 2036-2045.
25. Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, et al. (2005) Isolation and characterization of human antigen-specific TCRalphabeta+ CD4-CD8- double-negative regulatory T cells. Blood 105: 2828-2835.
26. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J Jr, et al. (1996) An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88: 3230-3239.
27. Kyttaris VC, Zhang Z, Kuchroo VK, Oukka M, Tsokos GC, (2010) Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J Immunol 184: 4605-4609.
28. Zhang Z, Kyttaris VC, Tsokos GC, (2009) The role of IL-23/IL-17 axis in lupus nephritis. J Immunol 183: 3160-3169.
29. Blazar BR, Taylor PA, Vallera DA, (1997) CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients. Transplantation 64: 571-576.
30. Sykes M, Szot GL, Nguyen PL, Pearson DA, (1995) Interleukin-12 inhibits murine graft-versus-host disease. Blood 86: 2429-2438.
31. Yang YG, Dey BR, Sergio JJ, Pearson DA, Sykes M, (1998) Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest 102: 2126-2135.
32. Li X, McKinstry KK, Swain SL, Dalton DK, (2007) IFN-gamma acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J Immunol 179: 939-949.
33. Boselli D, Losana G, Bernabei P, Bosisio D, Drysdale P, et al. (2007) IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions. Eur J Immunol 37: 2196-2204.
34. Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, et al. (2005) IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 201: 1925-1935.
35. Wei B, Baker S, Wieckiewicz J, Wood KJ, (2010) IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells. Am J Transplant 10: 69-80.
36. Bossi G, Griffiths GM, (1999) Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 5: 90-96.
37. Bradley LM, Duncan DD, Tonkonogy S, Swain SL, (1991) Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14-, CD45RB- helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4, and interferon gamma. J Exp Med 174: 547-559.
38. Balomenos D, Rumold R, Theofilopoulos AN, (1998) Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest 101: 364-371.
39. Haas C, Ryffel B, Le Hir M, (1997) IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J Immunol 158: 5484-5491.
40. Ma L, Chan KW, Trendell-Smith NJ, Wu A, Tian L, et al. (2005) Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains. Eur J Immunol 35: 3364-3375.
41. Kelley VE, Roths JB, (1985) Interaction of mutant lpr gene with background strain influences renal disease. Clin Immunol Immunopathol 37: 220-229.
42. Vidal S, Kono DH, Theofilopoulos AN, (1998) Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J Clin Invest 101: 696-702.
43. Shivakumar S, Tsokos GC, Datta SK, (1989) T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 143: 103-112.
44. Matzinger P, (1991) The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 145: 185-192.
45. Schulte M, Reiss K, Lettau M, Maretzky T, Ludwig A, et al. (2007) ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ 14: 1040-1049.